These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
276 related articles for article (PubMed ID: 25537088)
1. SPHK1 inhibitor suppresses cell proliferation and invasion associated with the inhibition of NF-κB pathway in hepatocellular carcinoma. Zhang Z; Yan Z; Yuan Z; Sun Y; He H; Mai C Tumour Biol; 2015 Mar; 36(3):1503-9. PubMed ID: 25537088 [TBL] [Abstract][Full Text] [Related]
2. [Sphingosine kinase 1 enhances the proliferation and invasion of human colon cancer LoVo cells through up-regulating FAK pathway and the expression of ICAM-1 and VCAM-1]. Liu SQ; Su YJ; Huang JA; Qin MB; Tang GD Zhonghua Zhong Liu Za Zhi; 2013 May; 35(5):331-6. PubMed ID: 24054007 [TBL] [Abstract][Full Text] [Related]
3. [Effect of sphingosine kinase 1 on the apoptosis, migration and invasion of colon cancer HT-29 cells and its molecular mechanisms]. Liu SQ; Qin MB; Huang JA; Zhong YY; Tang GD; Jiang HX Zhonghua Zhong Liu Za Zhi; 2011 Mar; 33(3):178-82. PubMed ID: 21575515 [TBL] [Abstract][Full Text] [Related]
4. Sphingosine kinase 1 enhances colon cancer cell proliferation and invasion by upregulating the production of MMP-2/9 and uPA via MAPK pathways. Liu SQ; Huang JA; Qin MB; Su YJ; Lai MY; Jiang HX; Tang GD Int J Colorectal Dis; 2012 Dec; 27(12):1569-78. PubMed ID: 22684547 [TBL] [Abstract][Full Text] [Related]
5. Naringenin suppresses TPA-induced tumor invasion by suppressing multiple signal transduction pathways in human hepatocellular carcinoma cells. Yen HR; Liu CJ; Yeh CC Chem Biol Interact; 2015 Jun; 235():1-9. PubMed ID: 25866363 [TBL] [Abstract][Full Text] [Related]
7. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells. Wu WL; Wang WY; Yao WQ; Li GD Int J Mol Med; 2015 Dec; 36(6):1713-9. PubMed ID: 26499886 [TBL] [Abstract][Full Text] [Related]
8. Sphingosine kinase 1 promotes tumour cell migration and invasion via the S1P/EDG1 axis in hepatocellular carcinoma. Bao M; Chen Z; Xu Y; Zhao Y; Zha R; Huang S; Liu L; Chen T; Li J; Tu H; He X Liver Int; 2012 Feb; 32(2):331-8. PubMed ID: 22098666 [TBL] [Abstract][Full Text] [Related]
9. Mannose-mediated inhibitory effects of PA-MSHA on invasion and metastasis of hepatocellular carcinoma via EGFR/Akt/IκBβ/NF-κB pathway. Li T; Dong ZR; Guo ZY; Wang CH; Zhi XT; Zhou JW; Li DK; Chen ZT; Chen ZQ; Hu SY Liver Int; 2015 Apr; 35(4):1416-29. PubMed ID: 25066210 [TBL] [Abstract][Full Text] [Related]
10. Role of Sphk1 in the malignant transformation of breast epithelial cells and breast cancer progression. Zheng XD; Zhang Y; Qi XW; Wang MH; Sun P; Zhang Y; Jiang J Indian J Cancer; 2014; 51(4):524-9. PubMed ID: 26842184 [TBL] [Abstract][Full Text] [Related]
11. Sphingosine kinase-1 enhances resistance to apoptosis through activation of PI3K/Akt/NF-κB pathway in human non-small cell lung cancer. Song L; Xiong H; Li J; Liao W; Wang L; Wu J; Li M Clin Cancer Res; 2011 Apr; 17(7):1839-49. PubMed ID: 21325072 [TBL] [Abstract][Full Text] [Related]
12. Pioglitazone, a PPARγ agonist, inhibits growth and invasion of human hepatocellular carcinoma via blockade of the rage signaling. Yang Y; Zhao LH; Huang B; Wang RY; Yuan SX; Tao QF; Xu Y; Sun HY; Lin C; Zhou WP Mol Carcinog; 2015 Dec; 54(12):1584-95. PubMed ID: 25307746 [TBL] [Abstract][Full Text] [Related]
13. The blockage of Ras/ERK pathway augments the sensitivity of SphK1 inhibitor SKI II in human hepatoma HepG2 cells. Zhang C; He H; Zhang H; Yu D; Zhao W; Chen Y; Shao R Biochem Biophys Res Commun; 2013 Apr; 434(1):35-41. PubMed ID: 23545258 [TBL] [Abstract][Full Text] [Related]
14. LncRNA HULC promotes non-small cell lung cancer cell proliferation and inhibits the apoptosis by up-regulating sphingosine kinase 1 (SPHK1) and its downstream PI3K/Akt pathway. Liu L; Zhou XY; Zhang JQ; Wang GG; He J; Chen YY; Huang C; Li L; Li SQ Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8722-8730. PubMed ID: 30575912 [TBL] [Abstract][Full Text] [Related]
15. Sphingosine kinase 1 promotes tumor progression and confers malignancy phenotypes of colon cancer by regulating the focal adhesion kinase pathway and adhesion molecules. Liu SQ; Su YJ; Qin MB; Mao YB; Huang JA; Tang GD Int J Oncol; 2013 Feb; 42(2):617-26. PubMed ID: 23232649 [TBL] [Abstract][Full Text] [Related]
16. Identification of sphingosine kinase 1 (SphK1) as a primary target of icaritin in hepatocellular carcinoma cells. Lu PH; Chen MB; Liu YY; Wu MH; Li WT; Wei MX; Liu CY; Qin SK Oncotarget; 2017 Apr; 8(14):22800-22810. PubMed ID: 28206952 [TBL] [Abstract][Full Text] [Related]
17. Artemisia capillaris extract AC68 induces apoptosis of hepatocellular carcinoma by blocking the PI3K/AKT pathway. Yan H; Jung KH; Kim J; Rumman M; Oh MS; Hong SS Biomed Pharmacother; 2018 Feb; 98():134-141. PubMed ID: 29253760 [TBL] [Abstract][Full Text] [Related]
18. Role of the novel HSP90 inhibitor AUY922 in hepatocellular carcinoma: Potential for therapy. Cheng W; Ainiwaer A; Xiao L; Cao Q; Wu G; Yang Y; Mao R; Bao Y Mol Med Rep; 2015 Aug; 12(2):2451-6. PubMed ID: 25955495 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of sphingosine kinase 1 ameliorates acute liver failure by reducing high-mobility group box 1 cytoplasmic translocation in liver cells. Lei YC; Yang LL; Li W; Luo P; Zheng PF World J Gastroenterol; 2015 Dec; 21(46):13055-63. PubMed ID: 26676341 [TBL] [Abstract][Full Text] [Related]
20. Basal and induced sphingosine kinase 1 activity in A549 carcinoma cells: function in cell survival and IL-1beta and TNF-alpha induced production of inflammatory mediators. Billich A; Bornancin F; Mechtcheriakova D; Natt F; Huesken D; Baumruker T Cell Signal; 2005 Oct; 17(10):1203-17. PubMed ID: 16038795 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]